Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emiko Mihara

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Nature Communications|June 22, 2021
Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori, et al.
Science Translational Medicine|February 16, 2022
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chainKana Hasegawa, Shunya Ikeda, Moto Yaga, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Nature Communications|June 22, 2021
Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori, et al.
Science Translational Medicine|February 16, 2022
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chainKana Hasegawa, Shunya Ikeda, Moto Yaga, et al.
Pageof 4